The average time to pay for SHIRE PHARMACEUTICAL CONTRACTS LIMITED has remained consistent at 30 days over the past three periods.
The percentage of invoices paid within 30 days has fluctuated between 74% and 76% over the past three periods, with a slight decrease in the most recent period.
Overall, there has been a slight decrease in the percentage of invoices paid within 30 days and an improvement in the percentage of invoices paid later than 60 days for SHIRE PHARMACEUTICAL CONTRACTS LIMITED over the past three periods. However, there is still room for improvement in terms of paying invoices within agreed terms.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | |||||
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 | 30 | 74% | 17% | 9% | 44% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Terms are calculated using invoice date
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
Dispute Resolution Process SSCE Shared Services Centre Europe (SSCE), based in Dublin, is responsible for maintaining supplier information, PO processing, invoice processing and payments. Please note the following important points about contacting us. We operate a ticketing system to ensure all queries are recorded and responded to within agreed timelines. All new queries will be assigned a Case Number and [ref: XXX] These numbers should be quoted on all replies to SSC. You’ll find it in the subject line of our auto-reply. Please use this case number if following up on your email or reply directly to our case email. https://www.shire.com/who-we-are/how-we-operate/policies-and-positions/supplier-information/europe#contact
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Shire Pharmaceutical Contracts Limited is a registered UK entity sharing its registered office at 1 Kingdom Street, London, with Takeda UK Limited. Its website now presents Takeda UK's corporate content, describing a headquartered London operation with over 300 employees focused on delivering medicines and vaccines. This reflects the entity's origins as part of Shire Pharmaceuticals, which became part of the Takeda group following acquisition. The company itself appears to function as part of this wider pharmaceutical group rather than as an independently trading business, with its own activity limited to a service or holding role within the Takeda corporate structure in the UK.
Generated from the company's website and Companies House records. Sources: shirepharmaceuticals.co.uk